Arcus Biosciences, Inc.
DOSING WITH AN AZOLOPYRIMIDINE COMPOUND

Abstract:

Provided herein are methods of treating a disease, disorder, or condition, mediated at least in part by the adenosine A.sub.2A N receptor (A.sub.2AR) and/or the adenosine A.sub.2B receptor (A.sub.2BR) using Compound (I). In some embodiments, the disease or disorder is a cancer related disorder. Also provided herein are pharmaceutical compositions and single unit dosages of Compound (I). ##STR00001##